Fidelity Investments’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Fidelity Investments’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,528,496	Closed	-$1.8M	–	4517
2019 Q4	$1.8M	Sell	1,528,496 -481,798	-24%	-$770K	﹤0.01%	2275
2019 Q3	$3.46M	Sell	2,010,294 -21,200	-1%	-$64.5K	﹤0.01%	2142
2019 Q2	$9.63M	Sell	2,031,494 -13,874	-0.7%	-$77.7K	﹤0.01%	1891
2019 Q1	$13.2M	Sell	2,045,368 -34,301	-2%	-$180K	﹤0.01%	1758
2018 Q4	$10.5M	Buy	2,079,669 +23,075	+1%	+$161K	﹤0.01%	1785
2018 Q3	$16.9M	Sell	2,056,594 -229,877	-10%	-$2.55M	﹤0.01%	1748
2018 Q2	$26.7M	Buy	+2,286,471	New	+$31.3M	﹤0.01%	1590

Other funds holding NTGN

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments's NTGN Position: Q1 2020 in Review

Fidelity Investments sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q1 2020, closing a stake of 1,528,496 shares — an estimated $1.8M sold.

Fidelity Investments first reported a position in NTGN in Q2 2018 and held it in 7 quarters. The position peaked at $26.7M in Q2 2018. 43 funds tracked by Wall St. Rank hold NTGN as of Q1 2020.

Fidelity Investments reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Fidelity Investments sold 1,528,496 Neon Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $1.8M.
Fidelity Investments first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 7 quarters.
Fidelity Investments's Neon Therapeutics, Inc. Common Stock position peaked at $26.7M in Q2 2018.
43 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Fidelity Investments's 13F filing for Q1 2020, filed 14 May 2020.